100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy

被引:0
作者
Michael L. Moritz
Juan Carlos Ayus
机构
[1] The University of Pittsburgh School of Medicine,Division of Nephrology, Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC
[2] Renal Consultants of Houston,undefined
来源
Metabolic Brain Disease | 2010年 / 25卷
关键词
Hyponatremia; Encephalopathy; Fluid therapy; Myelinolysis; Arginine vasopressin;
D O I
暂无
中图分类号
学科分类号
摘要
Hyponatremic encephalopathy is a potentially lethal condition with numerous reports of death or permanent neurological injury. The optimal treatment for hyponatremic encephalopathy remains controversial. We have introduced a unified approach to the treatment of hyponatremic encephalopathy which uses 3% NaCl (513 mEq/L) bolus therapy. Any patient with suspected hyponatremic encephalopathy should receive a 2 cc/kg bolus of 3% NaCl with a maximum of 100 cc, which could be repeated 1–2 times if symptoms persist. The approach results in a controlled and immediate rise in serum sodium with little risk of inadvertent overcorrection.
引用
收藏
页码:91 / 96
页数:5
相关论文
共 5 条
  • [1] 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy
    Moritz, Michael L.
    Ayus, Juan Carlos
    METABOLIC BRAIN DISEASE, 2010, 25 (01) : 91 - 96
  • [2] Treatment of Hyponatremic Encephalopathy With a 3% Sodium Chloride Protocol: A Case Series
    Ayus, Juan Carlos
    Caputo, Daniel
    Bazerque, Fernando
    Heguilen, Ricardo
    Gonzalez, Claudio D.
    Moritz, Michael L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (03) : 435 - 442
  • [3] Hypertonic (3%) sodium chloride for emergent treatment of exercise-associated hypotonic encephalopathy
    Siegel, Arthur J.
    SPORTS MEDICINE, 2007, 37 (4-5) : 459 - 462
  • [4] NaCl 3% Bolus Therapy as Emergency Treatment for Severe Hyponatremia: Comparison of 100 mL vs 250 mL
    Massop, Karen
    Haverkort, Dieneke A.
    Bech, Anneke P.
    de Boer, Hans
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (08) : e521 - e526
  • [5] Assessment of 2% vs 3% Peripheral Hypertonic Sodium Chloride Administration and Its Impact on Safe and Timely Treatment
    Olivia Dumont
    Nicole Davis
    Sara Radparvar
    Intensive Care Research, 2024, 4 (1): : 99 - 104